| |
| |
|
| Insider
Information: |
Elicker John E |
| Relationship: |
EVP, Investor Relations |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
70,946 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,181,928 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
70,946 |
|
|
| Total
Value |
$3,181,928 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 0.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
EVP, Investor Relations |
2020-03-10 |
70,946 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
EVP, Investor Relations |
• – – |
2020-03-10 |
4 |
D |
$57.93 |
$455,330 |
D/D |
(7,860) |
70,946 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Investor Relations |
• – – |
2020-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,835 |
76,240 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Investor Relations |
• – – |
2020-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,407 |
75,102 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Investor Relations |
• – – |
2020-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(102) |
62,741 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Investor Relations |
• – – |
2020-03-04 |
4 |
S |
$61.01 |
$964,263 |
D/D |
(15,805) |
58,666 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2019-11-05 |
4 |
S |
$56.66 |
$849,900 |
D/D |
(15,000) |
74,471 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2019-03-10 |
4 |
D |
$51.39 |
$233,311 |
D/D |
(4,540) |
89,471 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2019-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,180 |
92,626 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2019-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,137) |
84,974 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2018-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
793 |
73,434 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2018-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,043 |
86,932 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2018-03-10 |
4 |
D |
$67.92 |
$530,523 |
D/D |
(7,811) |
80,968 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2017-11-01 |
4 |
D |
$62.16 |
$13,862 |
D/D |
(223) |
67,943 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2017-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
494 |
68,166 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2017-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
919 |
59,243 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2017-03-10 |
4 |
D |
$58.32 |
$441,891 |
D/D |
(7,577) |
67,672 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2017-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(361) |
60,730 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2017-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,799 |
73,284 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2017-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
950 |
56,232 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2017-01-03 |
4 |
D |
$58.44 |
$19,870 |
D/D |
(340) |
55,892 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2016-11-01 |
4 |
D |
$50.80 |
$11,328 |
D/D |
(223) |
55,282 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2016-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
494 |
55,505 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2016-06-14 |
4 |
S |
$72.69 |
$859,219 |
D/D |
(11,820) |
55,011 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2016-03-10 |
4 |
D |
$64.94 |
$621,541 |
D/D |
(9,571) |
66,831 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Public Affairs & IR |
• – – |
2016-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,860 |
74,177 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
